Form D · Pharmaceuticals
PLX PHARMA INC.
Houston, TX · CIK 0001291520
Offering snapshot reported Mar 11, 2016 · SEC filing
- Reported sold
- $1.3M Offering amount: $2M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 23, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 11, 2016 | Initial | $1,297,000 | No comparison | 27 | SEC filing |
| Jul 8, 2013 | Initial | $9,000,000 | No comparison | 51 | SEC filing |
| Mar 19, 2013 | Initial | $8,273,297 | No comparison | 33 | SEC filing |
| Oct 5, 2011 | Initial | $2,893,965 | No comparison | 22 | SEC filing |
| Aug 9, 2010 | Initial | $2,000,020 | No comparison | 21 | SEC filing |
| Jul 9, 2009 | Initial | $3,106,961 | No comparison | 26 | SEC filing |
| May 7, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 18, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-259059
Source: Form D, filed Mar 11, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Anderson | Director |
| Gary Balkema | Director |
| Tim Black | Director |
| Kirk Calhoun | Director |
| Bob Casale | Director |
| Natasha Giordano | Director, Executive |
| John Hadden Ii | Director |
| David Jorden | Executive |
| Lenard M. Lichtenberger | Director |
| Peter Mann | Director |
| Upendra Marathi | Executive |
| Gary Mossman | Executive |
| Alexander F. Seelenberger | Director |
| Michael Valentino | Director |
| Ronald R. Zimmerman | Director, Executive |
| Ron Zimmerman | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
8285 El Rio Street Suite 130
Houston, TX, 77054
Houston, TX, 77054